DMAQR
Income statement / Annual
Last year (2024), Deep Medicine Acquisition Corp.'s total revenue was $21.86 M,
an increase of 6.19% from the previous year.
In 2024, Deep Medicine Acquisition Corp.'s net income was -$8.80 M.
See Deep Medicine Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
03/31/2021 |
| Operating Revenue |
$21.86 M |
$20.58 M |
$20.23 M |
$21.25 M |
$0.00 |
| Cost of Revenue |
$7.27 M
|
$8.54 M
|
$7.02 M
|
$5.26 M
|
$0.00
|
| Gross Profit |
$14.59 M
|
$12.05 M
|
$13.21 M
|
$15.98 M
|
$0.00
|
| Gross Profit Ratio |
0.67
|
0.59
|
0.65
|
0.75
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$15.98 M
|
$0.00
|
$11.57 M
|
$8.19 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$956.19 K
|
$601.31 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$15.98 M
|
$20.71 M
|
$2.17 M
|
$409.91 K
|
$59.40 K
|
| Other Expenses |
$706.21 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$16.69 M
|
$20.71 M
|
$2.17 M
|
$409.91 K
|
$59.40 K
|
| Cost And Expenses |
$23.96 M
|
$29.24 M
|
$2.17 M
|
$409.91 K
|
$59.40 K
|
| Interest Income |
$106.40 K
|
$1.62 M
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$6.93 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$639.84 K
|
$58.64 K
|
$226.20 K
|
$187.44 K
|
$0.00
|
| EBITDA |
-$1.22 M |
-$8.60 M |
-$2.17 M |
-$409.91 K |
-$59.40 K |
| EBITDA Ratio |
-0.06
|
-0.42
|
-0.11
|
-0.02
|
0
|
| Operating Income Ratio |
-0.1
|
-0.42
|
-0.11
|
-0.02
|
0
|
| Total Other Income/Expenses Net |
-$6.69 M
|
-$1.62 M
|
-$1.69 M
|
-$118.83 K
|
$5.00
|
| Income Before Tax |
-$8.80 M
|
-$10.28 M
|
-$342.66 K
|
-$414.05 K
|
-$59.40 K
|
| Income Before Tax Ratio |
-0.4
|
-0.5
|
-0.02
|
-0.02
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$57.57 K
|
-$187.44 K
|
$0.00
|
| Net Income |
-$8.80 M
|
-$10.28 M
|
-$400.23 K
|
-$414.05 K
|
-$59.40 K
|
| Net Income Ratio |
-0.4
|
-0.5
|
-0.02
|
-0.02
|
0
|
| EPS |
-0.76 |
-1.22 |
-0.14 |
-0.0252 |
-0.0036 |
| EPS Diluted |
-0.76 |
-1.22 |
-0.14 |
-0.0252 |
-0.0036 |
| Weighted Average Shares Out |
$11.63 M
|
$8.41 M
|
$6.62 M
|
$8.22 M
|
$8.22 M
|
| Weighted Average Shares Out Diluted |
$11.63 M
|
$8.41 M
|
$6.62 M
|
$8.22 M
|
$8.22 M
|
| Link |
|
|
|
|
|
